In February 2017, Cancer Treatment Centers of America executed the new Clinical Pathways program. This phenomenal program is centered on each individual patient and provides education on various treatment opportunities unique to each patient’s case. The Clinical Pathways program, made possible via collaboration with NantHealth and Allscripts, is focused on improving the quality of patient care and efficiency of care. The patient has the chance to review treatment regimens specific to their disease state and includes information about cost, clinical data, and even possible drug reactions. Each care regimen displayed to the patient includes data from previous patient cases, expected outcomes, cost of each particular treatment, and supporting research. This research provides information to both patient and physician that is unbiased and evidence based. With the Clinical Pathways program, the patient is able to analyze each option available to them and then review with their physician and discuss questions and concerns. The program also facilitates efficiency in obtaining approval from insurance companies by having supporting documentation readily available. The integrative and superior Clinical Pathways program is available to each patient at all five Cancer Treatment Centers of America locations.
Cancer Treatment Centers of America is nationally top ranked in many different areas. YouGovBrandIndex is a consumer research service that draws daily interviews from consumers around the United States. In YouGov’s 2017 Brand Health rankings, Cancer Treatment Centers of America scored the third ranking of hospitals in the United States. Cancer Treatment Centers of America consistently provides the highest quality of care for each individual patient. They provide an overwhelming support system for both the patient and their families during the treatment process while also keeping them well informed on different treatment opportunities. They understand the importance of having the best quality of life during the difficult battle the patient faces due to cancer.
To Learn More : www.myctca.com